Resumen de acción CYRX
Cryoport, Inc. ofrece soluciones de cadena de suministro a temperatura controlada en los mercados de biofarmacia/farmacia, salud animal y medicina reproductiva humana en América, Europa, Oriente Medio, África y Asia-Pacífico.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Competidores de Cryoport, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.03 |
| 52 Week High | US$24.17 |
| 52 Week Low | US$9.00 |
| Beta | 1.59 |
| 1 Month Change | -7.61% |
| 3 Month Change | 5.88% |
| 1 Year Change | -23.04% |
| 3 Year Change | -71.34% |
| 5 Year Change | 11.71% |
| Change since IPO | -85.56% |
Noticias y actualizaciones recientes
Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk
Apr 15
Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 15Recent updates
Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk
Apr 15Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 15Cryoport Tanks On Chilling Results And Bad Decisions
Mar 14Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Mar 10Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)
Jan 15Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Oct 06Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term
Jul 23Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity
Jul 12Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Jun 13Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 06Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially
Nov 07Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Sep 23Cryoport: A Rare Investing Opportunity
Sep 22Cryoport enters into strategic relationship with Takeda's BioLife Plasma Services
Sep 08Cryoport: Rapid Growth Is Great, But Shares Look Overpriced
Jul 30Cryoport: To Resume Aggressive Growth
May 11Cryoport: An Industry Leader Basking In Industry Tailwinds
Apr 15Cryoport: Risky Investment With Upside Potential
Apr 01Cryoport: More Growth Going Into New Year 2022
Dec 29Is Cryoport, Inc. (NASDAQ:CYRX) Trading At A 49% Discount?
Dec 05What Is Cryoport, Inc.'s (NASDAQ:CYRX) Share Price Doing?
Nov 09Is Cryoport (NASDAQ:CYRX) Using Too Much Debt?
Oct 17Cryoport: The Golden Stock
Oct 08Cryoport: Unfairly Punished, Valuation Update Shows 45% Upside
Oct 01Cryoport: Best Price-Positioned Medical Services Stock, As Seen By Market-Makers
Jul 01Is Cryoport, Inc. (NASDAQ:CYRX) Trading At A 47% Discount?
Jun 08Rentabilidad de los accionistas
| CYRX | US Life Sciences | Mercado US | |
|---|---|---|---|
| 7D | -2.7% | 3.6% | 1.0% |
| 1Y | -23.0% | 3.2% | 21.9% |
Rentabilidad vs. Industria: CYRX obtuvo unos resultados inferiores a los del sector US Life Sciences , que el año pasado arrojó un rendimiento del 5.2%.
Rentabilidad vs. Mercado: CYRX obtuvo unos resultados inferiores a los del mercado US, que fue del 24.7% el año pasado.
Volatilidad de los precios
| CYRX volatility | |
|---|---|
| CYRX Average Weekly Movement | 8.3% |
| Life Sciences Industry Average Movement | 6.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: CYRX no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de CYRX (8%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1999 | 1,025 | Jerry Shelton | www.cryoportinc.com |
Cryoport, Inc. ofrece soluciones para la cadena de suministro a temperatura controlada en los mercados de biofarmacia/farmacia, salud animal y medicina reproductiva humana en América, Europa, Oriente Medio, África y Asia-Pacífico. La empresa ofrece Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. También proporciona CRYOGENE, una solución sin parangón que ofrece servicios preclínicos de gestión de materiales biológicos a temperatura controlada que comprenden almacenamiento, procesamiento, recogida y recuperación de muestras; CRYOPD, una solución logística a temperatura controlada, que incluye soluciones de envasado y transporte a temperatura controlada desde temperatura criogénica hasta ambiente controlado; y servicios IntegriCell que comprenden recogida de aféresis/leucaféresis, transporte Cryoshuttle, optimización de crioprocesos y servicios de procesamiento.
Resumen de fundamentos de Cryoport, Inc.
| Estadísticas fundamentales de CYRX | |
|---|---|
| Capitalización bursátil | US$788.11m |
| Beneficios(TTM) | -US$107.59m |
| Ingresos (TTM) | US$233.26m |
3.4x
Ratio precio-ventas (PS)-7.3x
Ratio precio-beneficio (PE)¿Está CYRX sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CYRX | |
|---|---|
| Ingresos | US$233.26m |
| Coste de los ingresos | US$133.92m |
| Beneficio bruto | US$99.33m |
| Otros gastos | US$206.92m |
| Beneficios | -US$107.59m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -2.19 |
| Margen bruto | 42.59% |
| Margen de beneficio neto | -46.12% |
| Ratio deuda/patrimonio | 77.7% |
¿Cómo se ha desempeñado CYRX a largo plazo?
Ver rendimiento histórico y comparativa